Can Synchronous Chemotherapy be Added to Accelerated Hypofractionated Radiotherapy in Patients with Base of Tongue Cancer?
Authors:
- R. SwindellRSR. Swindell
- B. YapBYB. Yap
- L. LeeLLL. Lee
- A. SykesASA. Sykes
- K. MaisKMK. Mais
- P. SangheraPSP. Sanghera
- A. HartleyAHA. Hartley
- J. GlaholmJGJ. Glaholm
- N. SlevinNSN. Slevin
- 1 April 2010
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 22 (3) , 185-191
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up dataAnnals of Oncology, 2007
- Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized TrialJournal of Clinical Oncology, 2005
- Concomitant radiochemotherapy or accelerated radiotherapy: Analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC)Seminars in Oncology, 2004
- Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated RadiotherapyJournal of Clinical Oncology, 2004
- Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neckRadiotherapy and Oncology, 2004
- Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual dataThe Lancet, 2000
- Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx CarcinomaJNCI: Journal of the National Cancer Institute, 1999
- Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trialRadiotherapy and Oncology, 1997